跳至主要内容
临床试验/CTRI/2024/06/068682
CTRI/2024/06/068682尚未招募2 期

Pilot Study to assess the efficacy of cannabinoid-rich Oral cannabis extract for pain management in cancer patients undergoing cancer directed treatment (surgery, systemic therapy, radiation therapy)and who have received systemic analgesics - NI

Whole leaf Organics Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •Adult patients
  • •Histopathologically confirmed cancer diagnosis
  • •Moderate or severe pain
  • •Stable regime of pain management inclusive of NSAIDS weak opioid opioids
  • •Palliative intent therapy

排除标准

  • •Major psychiatric disorder
  • •Cardiovascular disorder
  • •Significant renal or hepatic impairment
  • •Lactating Women
  • •Patients who were currently using or had used cannabinoid based medications within 30
  • •days of study entry

研究者

发起方
Whole leaf Organics Pvt Ltd

相似试验